Related Experiment Videos
The Federal 'Right To Try' Act: An Answer to New Treatments During Terminal Illness?
Journal of the Advanced Practitioner in Oncology
|July 19, 2018
Abstract:
The newly proposed Federal "Right to Try" Act permits terminally ill patients to try experimental therapies that have completed phase I testing but have not been approved by the FDA. However, there are concerning provisions of the legislature regarding liability and costs.